News | Breast Density | December 19, 2018

Agreement integrates densitasdensity breast density analysis software with Blackford Platform

Densitas Enters Platform Partnership With Blackford

December 19, 2018 — Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford. This agreement gives Blackford the right to promote, market, sell, distribute and license densitasdensity directly via integration with the Blackford Platform. Work will now commence to integrate densitasdensity with the Blackford Platform. Densitas CEO Mohamed Abdolell said integrating with Blackford will shorten Densitas’ time to market and shorten the sales cycle.

The densitasdensity software provides an automated mechanism for quantifying and recording percent breast tissue density, and making it readily available to the radiologist. Beyond speeding and simplifying the process of quantifying breast density, densitasdensity standardizes the density measurement. This enables uniform application of risk-based stratification of screen-eligible women aimed at ensuring those who need more aggressive follow-up receive it, while those who do not need aggressive follow-up do not receive unnecessary imaging. Densitas said the software is unique because it assesses breast density using the routinely archived processed DICOM images that radiologists normally review, and therefore supports prospective and retrospective breast density measurement for clinical care and for research.

densitasdensity was demonstrated at the Radiological Society of North America (RSNA) 2018 annual meeting, Nov. 25-30 in Chicago.

For more information: www.densitas.health, www.blackfordanalysis.com


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Ultrasound Women's Health

Sept. 29, 2026 — A research team at the University of Virginia (UVA) led by Timothy Bullock, PhD, has published results ...

Time September 30, 2026
arrow
News | Breast Imaging

Sept. 10, 2026 — An artificial intelligence model that analyzes women's past and recent annual 3D mammograms is more ...

Time September 10, 2026
arrow
Subscribe Now